Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor

Author： Omar Aadilah   Jovanovic Katarina   Da Costa Dias Bianca   Gonsalves Danielle   Moodley Kiashanee   Caveney Robert   Mbazima Vusi   Weiss Stefan FT  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.21, Iss.1, 2011-01, pp. : 35-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer

By  

Current Pharmaceutical Design, Vol. 23, Iss. 32, 2017-12 ,pp. : 4745-4757

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of a 40-kDa catecholamine regulated protein by dopamine receptor antagonists

By Sharan N.   Nair  

European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite

Modulation of a 40-kDa catecholamine-regulated protein following d-amphetamine treatment in discrete brain regions

By Gabriele J.   Rajaram M.   Zhang B.   Sharma S.   Mishra R.K.  

European Journal of Pharmacology, Vol. 453, Iss. 1, 2002-10 ,pp. : 13-19

Elsevier

Access to resources Recommend Favorite

Peginterferon-α2a (40 kDa) for chronic hepatitis C

By Hadziyannis Stephanos J   Papatheodoridis George V  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 541-551

Informa Healthcare

Access to resources Recommend Favorite

Humoural Immune Responses to a Recombinant 16-kDa–38-kDa–ESAT-6 Mycobacterial Antigen in Tuberculosis

By Wu L   Zhang M   Sun M   Jia B   Wang X  

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 514-521

Field House Publishing

Access to resources Recommend Favorite